Mice with myeloid-specific ablation of PD-1 lacked GMPs and MDSCs, had increased numbers of systemic effector myeloid cells and T effector memory cells, and showed inhibition of tumor growth [19]. The gene discussed is PDCD1; the disease is neoplasm.